Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Stimulators of immunogenic cell death for cancer therapy: focusing on natural compounds
Mina Amiri, Ommoleila Molavi, Shahnaz Sabetkam, et al.
Cancer Cell International (2023) Vol. 23, Iss. 1
Open Access | Times Cited: 21

Showing 21 citing articles:

Green-synthesized silver nanoparticles from peel extract of pumpkin as a potent radiosensitizer against triple-negative breast cancer (TNBC)
Soheila Montazersaheb, Aziz Eftekhari, Amir Shafaroodi, et al.
Cancer Nanotechnology (2024) Vol. 15, Iss. 1
Open Access | Times Cited: 29
Arsenic trioxide augments immunogenic cell death and induces cGAS-STING-IFN pathway activation in hepatocellular carcinoma
Xin Li, Yu‐Fei Pan, Yibin Chen, et al.
Cell Death and Disease (2024) Vol. 15, Iss. 4
Open Access | Times Cited: 12
Emerging role of immunogenic cell death in cancer immunotherapy: Advancing next-generation CAR-T cell immunotherapy by combination
Zhaokai Zhou, Yumiao Mai, Ge Zhang, et al.
Cancer Letters (2024) Vol. 598, pp. 217079-217079
Closed Access | Times Cited: 12
Repurposing chemotherapeutics in a hyaluronic acid-conjugate combination treatment approach for the local immunomodulation of the glioblastoma microenvironment
Giulia Rodella, Zhanjun Ma, Bernard Učakar, et al.
International Journal of Pharmaceutics (2025), pp. 125612-125612
Open Access | Times Cited: 1
Challenges of Regulated Cell Death: Implications for Therapy Resistance in Cancer
Maria D’Amico, Francesca De Amicis
Cells (2024) Vol. 13, Iss. 13, pp. 1083-1083
Open Access | Times Cited: 7
Reactive oxygen species of tumor microenvironment: Harnessing for immunogenic cell death
Rama Rao Malla, Seema Kumari, Swapna Priya Ganji, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2024) Vol. 1879, Iss. 5, pp. 189154-189154
Closed Access | Times Cited: 7
An antigen-capturing and lymph node-targeting nanoparticle for cancer immunotherapy
Zhen Zhang, Xu Chen, Ningqiang Gong, et al.
Journal of Controlled Release (2025) Vol. 379, pp. 993-1005
Closed Access
Role of liposomes in chemoimmunotherapy of Breast cancer
Fatemeh Attarian, Ghazaleh Hatamian, Shamim Nosrati, et al.
Journal of drug targeting (2025), pp. 1-43
Closed Access
Biomimetic Multifunctional Nanoparticles for Improved Radiotherapy and Immunotherapy in Cancer Treatment
Jiale Chen, Pan Ran, Yu Xu, et al.
Materials Today Bio (2025), pp. 101698-101698
Open Access
Design strategies for hyaluronic acid-based drug delivery systems in cancer immunotherapy
Giulia Rodella, Véronique Préat, Bernard Gallez, et al.
Journal of Controlled Release (2025), pp. 113784-113784
Open Access
Dual Role of Alchemilla vulgaris L. Extract in Breast Cancer Regression: Reestablishment of Effective Immune Response
Sanja Jelača, Ivan Jovanović, Dijana Bovan, et al.
Pharmaceuticals (2024) Vol. 17, Iss. 3, pp. 286-286
Open Access | Times Cited: 3
Induction of immunogenic cell death and enhancement of the radiation-induced immunogenicity by chrysin in melanoma cancer cells
Sevda Jafari, Alireza Khodaei Ardakan, Elnaz Mehdizadeh Aghdam, et al.
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 2
Reactive oxygen species: Janus-faced molecules in the era of modern cancer therapy
Aine O’Reilly, Wenchao Zhao, Stina L. Wickström, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 12, pp. e009409-e009409
Open Access | Times Cited: 2
The Ability of Clinically Relevant Chemotherapeutics to Induce Immunogenic Cell Death in Squamous Cell Carcinoma
Zhenjie He, Xinming Jing, Xiaoyan Dai, et al.
Frontiers in Bioscience-Landmark (2024) Vol. 29, Iss. 4
Open Access | Times Cited: 1
CRISPR/Cas9-mediated knockout strategies for enhancing immunotherapy in breast cancer
Chenchen Xu
Naunyn-Schmiedeberg s Archives of Pharmacology (2024) Vol. 397, Iss. 11, pp. 8561-8601
Closed Access | Times Cited: 1
Derivatization of Abietane Acids by Peptide-like Substituents Leads to Submicromolar Cytotoxicity at NCI-60 Panel
E. V. Tret’yakova, Anna Smirnova, Denis A. Babkov, et al.
Molecules (2024) Vol. 29, Iss. 15, pp. 3532-3532
Open Access | Times Cited: 1
AIEgen-self-assembled nanoparticles with anti-PD-L1 antibody functionalization realize enhanced synergistic photodynamic therapy and immunotherapy against malignant melanoma
Li Lü, Qing Xu, Xiuzhen Zhang, et al.
Materials Today Bio (2024) Vol. 30, pp. 101387-101387
Open Access | Times Cited: 1
Discovery of a Chimeric Polyketide Family as Cancer Immunogenic Chemotherapeutic Leads
Dan Xue, Mingming Xu, Michael R. Madden, et al.
Journal of the American Chemical Society (2024)
Open Access | Times Cited: 1
Autophagy activator-loaded bicomponent peptide nanocarriers for phototherapy-triggered immunity enhancement against metastatic breast cancer
Teng Ma, Danqi Li, Zhuoran Yang, et al.
Journal of Controlled Release (2024) Vol. 376, pp. 241-252
Closed Access
Discovery of A Chimeric Polyketide Family as Cancer Immunogenic Chemotherapeutic Leads
Dan Xue, Mingming Xu, Michael R. Madden, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
Immunogenic cell death: A new strategy to enhancing cancer immunotherapy
Lei Dou, Yu Fang, Huiyuan Yang, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access
Identification of phytomolecules as isoform and mutation specific PI3K-α inhibitor for protection against breast cancer using e-pharmacophore modeling and molecular dynamics simulations
Ajay Mili, Sumit Birangal, Jyothi Giridhar, et al.
BMC Chemistry (2024) Vol. 18, Iss. 1
Open Access
Page 1

Scroll to top